Zobrazeno 1 - 10
of 192
pro vyhledávání: '"Bruno Fuchs"'
Autor:
Bruno Fuchs, Beata Bode, Philip Heesen, Barbara Kopf, Christian Michelitsch, Manfred Odermatt, Pietro Giovanoli, Stefan Breitenstein, Paul Schneider, Guido Schüpfer, Stefan Boes, Gabriela Studer
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 4 (2024)
No abstract available.
Externí odkaz:
https://doaj.org/article/fc945c538d6945ef837507263501e75f
Publikováno v:
Reports, Vol 7, Iss 2, p 35 (2024)
Bone tumors often manifest with non-specific symptoms such as pain and swelling, often posing diagnostic challenges. Optimal treatment requires centralized care in specialized centers, emphasizing the need for complete tumor removal and interdiscipli
Externí odkaz:
https://doaj.org/article/13254859f2294ebf91e77f25ea368736
Autor:
Veronika Blum, Vanghelita Andrei, Baptiste Ameline, Silvia Hofer, Bruno Fuchs, Klaus Strobel, Anna Allemann, Beata Bode, Daniel Baumhoer
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Mesenchymal chondrosarcoma is a rare and aggressive sarcoma subtype with high risk for distant metastases and poor prognosis. Currently NCCN- and ESMO-Guidelines recommend using Ewing sarcoma protocols as standard treatment. Nevertheless, in localize
Externí odkaz:
https://doaj.org/article/b91aeeda9dcb480d83a630b4844bd781
Autor:
Nasian Mosku, Philip Heesen, Salome Christen, Mario F. Scaglioni, Beata Bode, Gabriela Studer, Bruno Fuchs
Publikováno v:
Diagnostics, Vol 13, Iss 6, p 1206 (2023)
Patient-based health related quality of life (HRQoL) measurements are associated with an improvement in quality of care and outcomes. For a complex disease such as sarcoma, there is no disease-specific questionnaire available which covers all clinica
Externí odkaz:
https://doaj.org/article/ac0b677282d84fd5b0bc396fd89d9639
Publikováno v:
Sarcoma, Vol 2022 (2022)
Soft tissue tumors are rare tumors, and their histological examination remains a challenge. The establishment of the correct initial histopathologic diagnosis is critical. However, due to the rarity of soft tissue and bone tumors and the inherent dif
Externí odkaz:
https://doaj.org/article/d85aced40f254673aa8d406e41872876
Autor:
Bruno Fuchs, Gabriela Studer, Beata Bode, Hanna Wellauer, Annika Frei, Carlo Theus, Guido Schüpfer, Jan Plock, Hubi Windegger, Stefan Breitenstein
Publikováno v:
Swiss Medical Weekly, Vol 151, Iss 5152 (2021)
The urgent need to restructure healthcare delivery to address rising costs has been recognised. Value-based health care aims to deliver high and rising value for the patient by addressing unmet needs and controlling costs. Sarcoma is a rare disease a
Externí odkaz:
https://doaj.org/article/816b882d7acc4ed1a15e08e58b72091c
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 1, Pp 537-541 (2019)
Purpose: Desmoids are locally infiltrative, nonmalignant soft tissue tumors. Surgery, radiation therapy, and chemotherapy have been the mainstay of treatment, but relapse is common and side effects can result in significant morbidity. MR-HIFU is incr
Externí odkaz:
https://doaj.org/article/fd04ee159eb64caa8ebd323f93fa36a4
Autor:
Matthias J. Arlt, Aleksandar Kuzmanov, Jess G. Snedeker, Bruno Fuchs, Unai Silvan, Adam A. Sabile
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Fascin-1, a prominent actin-bundling protein, is found to be upregulated in several human carcinomas. While it is accepted that Fascin-1 expression correlates with poor clinical outcome and decreased survival in various carcinomas
Externí odkaz:
https://doaj.org/article/cd3fc8a215b74136b7e71cbc44d4daa7
Publikováno v:
Medicina, Vol 58, Iss 1, p 67 (2022)
Background and Objectives: The definitive treatment of soft tissue sarcomas (STS) requires a radical surgical removal of the tumor, which often leads to large soft tissue defects. When they are located in the limbs, significant damage to the lymphati
Externí odkaz:
https://doaj.org/article/07bd2b844fb348789c0fd977106e7e9c
Autor:
Bernhard Robl, Sander Martijn Botter, Aleksandar Boro, Daniela Meier, Dario Neri, Bruno Fuchs
Publikováno v:
Translational Oncology, Vol 10, Iss 3, Pp 419-430 (2017)
The targeted delivery of tumor necrosis factor-α (TNF-α) with antibodies specific to splice isoforms of fibronectin [e.g., F8-TNF, specific to the extra-domain A (EDA) domain of fibronectin] has already shown efficacy against experimental sarcomas
Externí odkaz:
https://doaj.org/article/1c4f6b5718514ca1ba9e63c9e5951d87